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Abstract: Oleanolic acid (OA), a triterpene that is highly present in olive leaves, has been pro-
posed as a component of functional foods for the prevention of metabolic syndrome, due to its
anti-inflammatory activity. We analyzed the effects of OA on inflammatory parameters and signaling
proteins in LPS-stimulated THP-1 macrophages. Thus, THP-1 macrophages were incubated with
LPS for 48 h after pretreatment with OA at different concentrations. Pretreatment with OA was
significantly effective in attenuating IL-6 and TNF-α overproduction induced by LPS in macrophages,
and also improved the levels of AMPK-α. We also evaluated the effects of human triglyceride-rich
lipoproteins (TRLs) derived from individuals consuming an OA-enriched functional olive oil. For
this purpose, TRLs were isolated from healthy adolescents before, 2 and 5 h postprandially after the
intake of a meal containing the functional olive oil or common olive oil, and were incubated with
THP-1 macrophages. THP-1 macrophages incubated with TRLs isolated at 2 h after the consumption
of the OA-enriched olive oil showed significant lower levels of IL-6 compared to the TRLs derived
from olive oil. Our results suggest that OA might have potential to be used as a lipid-based formu-
lation in functional olive oils to prevent inflammatory processes underlying metabolic syndrome
in adolescents.
Keywords: oleanolic acid; olive oil; functional foods; postprandial trial; human triglyceride-rich
lipoproteins; metabolic syndrome; obesity; insulin resistance; adolescents; THP-1 macrophages
1. Introduction
Metabolic syndrome (MetS) is a worrying health public problem that affects approxi-
mately 31% of the world population, and it is expected that its prevalence will increase by
about 53% by 2035 [1,2]. The International Diabetes Federation defines central obesity as
the unique fixed component of MetS [3]. In fact, inadequate control of abdominal obesity
and insulin resistance (IR), among others, not only lead to the development of Type 2
Diabetes Mellitus (T2DM) and cardiovascular diseases, but also to other clinical disorders,
such as oxidative stress, non-alcoholic fatty liver disease and hepatic steatosis [4–6].
Obesity is characterized by an excess of fat accumulation in the adipose tissue [7], in
which the inflammatory response is closely linked to the development of IR [8]. Chronic
inflammation of adipose tissue in obesity causes an impairment in the polarization of adi-
pose tissue macrophages (ATMs), resulting in a higher presence of the M1 proinflammatory
phenotype [8–10]. As a consequence, ATMs are involved in the release of proinflammatory
cytokines, such as interleukin-6 (IL-6), interleukin-1β (IL-1β) and tumor necrosis factor-α
(TNF-α) [11,12]. These proinflammatory cytokines are positively regulated by the nuclear
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transcription factor kappa B (NF-κB), which is translocated to the cell nucleus after acti-
vation of IκB kinase (IKK). Another kinase with an important role in NF-κB function is
AMP-activated protein kinase (AMPK), in which its activation inhibits NF-κB signaling.
Both AMPK and IKK also participate in insulin signaling through acting on the insulin
receptor substrate [13]. These pathways that are associated with obesity-induced inflamma-
tion have been considered as potential targets in the research of new bioactive compounds
or drugs for treating obesity and IR, two of the main factors underlying MetS.
Sedentary and unhealthy lifestyles, both in adults and in adolescents, makes the search
of new preventive and therapeutic interventions to fight MetS necessary [14]. Moreover,
the worrying comorbidities derived from MetS together with the expensive tendency of
the pharmacological interventions used for preventing and controlling this syndrome
jeopardize the stability of the healthcare systems [15]. The Seven Country Study accom-
plished in the 1950s first proved the cardioprotective abilities and health benefits of the
Mediterranean diet [16]. Since then, intervention studies based on the Mediterranean diet
have gained importance for their beneficial effects on the components of MetS, such as
obesity, hyperlipidemia, hyperglycemia and hypertension [17]. The key constituent of the
Mediterranean diet is virgin olive oil, which possesses anti-inflammatory and antioxidant
properties that are not only due to the high levels of oleic acids, but also to the presence of
minor compounds, such as phenolic derivatives, phytosterols, carotenoids, tocopherols
and terpenoids [18,19].
There is increasing interest in performing clinical trials to study the preventive and ther-
apeutic effects of virgin olive oil minor compounds on MetS. Sánchez-Rodríguez et al. [20]
have recently presented the results of a randomized controlled trial with 51 healthy indi-
viduals who consumed a functional olive oil enriched in their phenolics and triterpenes
for three weeks, showing that this dietary intervention decreased urinary DNA oxidation
and plasma inflammatory biomarkers, in comparison with the intake of a standard vir-
gin olive oil. In addition, the PREDIABOLE study, a randomized controlled trial with
176 prediabetic patients demonstrated that the consumption of an oleanolic acid-enriched
olive oil for 30 months improved insulin resistance and diminished the risk of developing
T2DM by 55% [21]. Oleanolic acid (OA; (3β)-3-hydroxyolean-12-en-28-oic acid) is a penta-
cyclic triterpene widely distributed in the plant kingdom, which is significantly abundant
in the fruit and leaf from the olive tree [22], and is therefore a natural component of virgin
olive oil [23]. This triterpene possesses anti-inflammatory, anti-oxidant, anti-atherosclerotic
and anti-hypertensive activities [22,24], but the pathways involved in these properties
are not fully understood. However, it is suggested that OA could be entangled in the
repression of the NF-κB and in the activation of the nuclear factor erythroid 2–related factor
2 (Nrf2), two important transcription factors that modulate the inflammatory status in
insulin resistance [25,26].
Therefore, a better understanding of the action of OA in a metabolic syndrome context
is still necessary. For this reason, our study aimed to evaluate the effects of OA on the
production of the pro-inflammatory cytokines and on signaling proteins in LPS-stimulated
THP-1 macrophages. We also studied for the first time the potential capacity of OA to
be used in functional foods in order to prevent IR and MetS, by assessing the effects of
postprandial TRLs obtained from healthy adolescents after the intake of a meal containing
an OA-enriched olive oil.
2. Materials and Methods
2.1. Materials
A scanning multi-well spectrophotometer (Multiskan spectrum, Thermo Fisher Sci-
entific, Waltham, MA, USA) was utilized to measure absorbances. RPMI 1640 medium,
fetal bovine serum (FBS), penicillin, streptomycin and phosphate buffered saline (PBS)
were purchased from Biowest (Nuaillé, France). Lipopolysaccharide (LPS) (from E. coli
0111:B4) and phorbol 12-myristate-13-acetate (PMA) were purchased from Sigma-Aldrich
(St. Louis, MO, USA).
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2.2. OA Obtaining and Elaboration of the Functional Olive Oil
2.2.1. OA Obtaining
OA was obtained from olive tree leaves following the method developed by Albi et al. [27].
In brief, OA was extracted from leaves using 96% ethanol (20 mL/g) at room temperature.
To facilitate the formation of OA crystals, the extract was filtered and vacuum concentrated.
OA crystals were washed with cold 96% ethanol (5–7 ◦C) and filtered to remove pigment
traces and other possible contaminants. Finally, the crystals were heated at 165 ◦C, and
homogenized to a powder. OA purity was determined by gas chromatography.
2.2.2. Analysis of OA by Gas Chromatography (GC)
Prior to derivatization, 100 µL of a methanolic solution of betulinic acid (0.5 mg/mL)
was added as an internal standard to 100 µL of the OA-containing sample. The mixture
was evaporated to dryness under a N2 stream, and the residue dissolved in 200 µL of the
silylating reagent (BSTFA + 1% TMCS in pyridine).
OA was identified and quantified using a coupled GC–mass spectrometry detector
(GC-MS) QP2010 Ultra (Shimadzu Europa GmbH, Duisburg, Germany) with an AOC-20i
autosampler, an ion source of electron impact and a quadrupole detector. The analysis
was carried out in splitless mode, with an injector temperature of 290 ◦C. Helium was
used as a carrier gas at 53.1 kPa and of 1mL/min. The oven temperature program was
as follows: initial temperature, 50 ◦C/1min; 50–200 ◦C at 40 ◦C/min; 200–280 ◦C at
10 ◦C/min; and finally held for 2 min. Total run time was 14.75 min. The MS conditions
were: interface temperature, 280 ◦C; ion source temperature, 220 ◦C; electron impact, 70 eV;
acquisition mode, scan (m/z 50–600). OA was identified by comparing the retention times
and abundance ratios of two fragments ions (203 and 189 m/z).
2.3. Elaboration and Characteristics of the Functional Olive Oil
The functional olive oil used in the postprandial trial was elaborated by adding OA at
a concentration of 610 mg/kg to a commercial olive oil. No adjuvants were added. The
control olive oil was the same as that of the functional olive oil, but without adding OA.
Green-colored flasks were used for bottling of the functional and non-functional olive oils,
and were labeled with a bicolor code system for blinding. Each dose of the functional oil
consisted of 55 mL, containing 30 mg of OA.
Representative chemical compositions of the oils are shown in Table S1 (see the
supplementary materials). OA concentrations in the control and in the functional olive oil
were 3.8 ± 0.1 mg/kg oil and 610.4 ± 16.2 mg/kg oil, respectively.
2.4. Preparation of OA Used in the LPS-Stimulated THP-1 Macrophages
When OA was directly administered to LPS-stimulated THP-1 macrophages, it was
dissolved in DMSO. To achieve the concentrations of 0.5, 1, 5, 10 and 25 µM, increased
volumes of this solution were employed. Thus, for higher OA concentrations, higher
volumes of DMSO were added to cells.
2.5. Postprandial Trial
2.5.1. Design and Implementation of the Study
We performed a randomized, controlled and double-blind postprandial trial with
adolescents to obtain postprandial TRLs as circulating OA vehicle when the triterpene was
administered as functional olive oil. The study was carried out in accordance with the
Helsinki declaration and authorized by the research ethics committee of the University
Hospitals Virgen de la Macarena and Virgen del Rocío in Seville, Spain. This trial was
registered at ClinicalTrials.gov (Identifier: NCT05049304).
2.5.2. Setting and Participants
Twenty-two healthy and normal weight adolescents of both sexes (aged 16–17 years-old)
participated in the postprandial trial. The participants were recruited from a high school in
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the province of Granada (Spain), and their health status was checked through a complete
biochemical analysis. Participants did not suffer from digestive, metabolic or oncologic
disorders, or any other pathology. For their inclusion in the trial, it was also required
that their parents granted the written consent to the approved protocols, after being
conveniently informed both orally and by written means. The fieldwork was performed
in the high school. Eleven adolescents were randomly assigned to the intervention group
(OA-enriched functional olive oil), and the other eleven participants to the control one (the
same commercial olive oil not enriched in OA).
The determination of the sample size for the postprandial trial was calculated consid-
ering plasma OA concentration as the quantitative variable. As there are no population
data, a cohort of 60 participants from the control group of the PREDIABOLE study was
used. A confidence of 95% (α risk = 0.05; 1.645) and a power of 90% (zβ = 1.282), were
used, yielding a sample size of 15 participants. Taking into account possible losses, sample
size was finally augmented to 22 participants.
2.5.3. Anthropometric Assessment and Body Composition Analysis
The intervention was carried out after 12 h of overnight fasting. Anthropometric
measurements were performed individually according to the recommendations of the
International Society for the Advancement of Kinanthropometry (ISAK) [28] in a classroom
provided by the high school to guarantee the privacy of each adolescent. We used a
body composition analyzer (TANITA® model BC-418MA, West Drayton, UK) to measure
the body weight and the percentage of body fat. Height was measured twice with a
±5 mm precision with a Seca 214* portable stadiometer, and the average of the two
values was used in the analysis. The body mass index (BMI) was obtained by dividing
the body weight in kilograms by the height in meters squared. We measured waist
circumference (WC) in the middle distance from the lowest rib to the upper border of the
iliac crest at the end of a normal exhalation using a Seca automatic roll-up measuring tape
(precision of 1 mm). Blood pressure (BP) levels were determined using a calibrated aneroid
sphygmomanometer and a Littmann® stethoscope (Saint Paul, MN, USA), according to
international recommendations [29]. Adolescents self-reported their pubertal development
based on the Tanner stages [30].
2.5.4. Intervention
On the trial day, and after 12 h of overnight fasting, blood samples were drawn from
the cubital vein. Subsequently, participants took an experimental breakfast that consisted
of 150 mL skimmed milk, a tablespoon of crushed tomato, three slices of whole meal bread,
and 55 mL of the assigned oil (equivalent dose of OA 30 mg, in the case of the functional
olive oil). After eating the respective breakfasts, aliquots of cubital blood were drawn
at 2 and 5 h in the postprandial period. During that time, free access to water intake
was allowed.
2.5.5. Biochemical Determinations and Isolation of TRLs
Aliquots of cubital blood samples were drawn before, and at 2 and 5 h after the
breakfast intake. All blood samples were centrifuged at 3000 rpm for 5 min at 20 ◦C, and
aliquots of serum were frozen until their use for determining biochemical parameters at
baseline or isolating TRLs.
Serum levels of fasting glucose, high-density lipoprotein cholesterol (HDL-c), total
cholesterol (TC) and triglycerides (TG) were measured by means of enzymatic colorimetric
methods. The Friedewald equation ((LDLC) = (Total Cholesterol) − (HDL-c) − ([TG]/5))
was used for estimating low-density lipoprotein cholesterol (LDL-c) [31]. Fasting insulin
serum levels were determined using an ELISA kit (Diaclone, Besançon, France) according
to the manufacturer’s instructions. HOMA-IR was calculated using the following equation:
fasting glycemia (mmol/L) × fasting insulin (mU/L)/22.5.
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Once thawed, 4–4.5 mL of serum was layered under 6 mL of 0.9% NaCl solution
(d = 1.006 Kg/L), and ultracentrifuged at 39.000 rpm for 16 h at 12 ◦C in a preparative
ultracentrifuge Beckman Coulter L90K (Beckman Instruments, Inc., Palo Alto, CA, USA).
Finally, the upper off-white phase of each tube, containing TRLs, was collected.
2.6. THP-1 Monocytes Culture
THP-1 monocytes (3–8 × 105 cells/mL) were cultured in RPMI-1640 medium supple-
mented with antibiotics (100 U/mL streptomycin and 100 U/mL penicillin) and 10% heat-
inactivated fetal bovine serum (FBS), under a 100% humidified atmosphere of air + 5% CO2
at 37 ◦C. Cells were passaged every 2 to 3 days to maintain growth.
2.7. Differentiation of THP-1 Monocytes into Macrophages
THP-1 monocytes were seeded at 1 × 106 cells/mL in cell culture dishes, and incubated
with PMA (0.2 µg/mL) at 37 ◦C in 5% CO2–95% air to induce their differentiation into
macrophages. After incubation for 72 h, cells were washed with preheated RPMI-1640
medium supplemented with antibiotics to eliminate the excess of PMA and undifferentiated
monocytes. The confluency of adherent cells was 70–80% in all cell-culture experiments,
and cell viability was >95%. Finally, THP-1 macrophages were maintained with RPMI-1640
medium supplemented with antibiotics for 24 h at 37 ◦C in 5% CO2–95% air, until the
addition of the experimental (OA or TRL) or vehicle.
2.8. Cell Viability Assay in THP-1 Macrophages Pretreated with OA
THP-1 macrophages were pretreated with OA at different concentrations (0.5 to 25 µM)
for 1 h. LPS was added to OA-pretreated THP-1 macrophages for 48 h at 37 ◦C in 5%
CO2–95% air. DMSO was added to control cells. The XTT assay was performed following
the instructions of the manufacturer’s kit (Canvax Biotech, Córdoba, Spain) to determine
the cell viability. Absorbance was measured at 450 nm. Cell viability was calculated using
the equation: (mean OD treated cells/mean OD control cells) × 100.
2.9. Determination of Proinflammatory Cytokines and Kinases in LPS-Stimulated THP-1
Macrophages Pretreated with OA
THP-1 macrophages were pretreated for 1 h with OA (0.5, 1, 5, 10 and 25 µM), followed
by LPS (100 ng/mL) for 48 h at 37 ◦C in 5% CO2–95% air. DMSO was added to control cells.
All experiments were performed in triplicate. Once the incubation period was finished,
culture media were collected and the IL-6, IL-1β and TNF-α levels were measured using
ELISA kits (Diaclone, Besançon, France; RayBiotech, Norcross, GA, USA; and Cloud-Clone,
Katy, TX, USA, respectively). Furthermore, THP-1 macrophages were washed with PBS,
scraped off the plates and lysed by sonication twice for 50 s at 50 W. The protein content
of the lysate was measured using the Bradford protein assay [32]. Cell lysates were used
for measuring the presence of Akt and AMPK-α with ELISA kits (ThermoFisher, Carlsbad,
CA, USA). ELISA assays were performed according to the manufacturer’s instructions and
absorbance was read at 450 nm.
2.10. TRL Stimulation of THP-1-Derived Macrophages and Determination of Proinflammatory
Cytokines and Kinases
Appropriate volumes of TRL to achieve a concentration of 25 µg apoB/total protein
were added to THP-1 macrophages. PBS (50 µL per mL of cell culture) was added to
macrophages as a vehicle in triplicate. After 48 h of incubation at 37 ◦C in 5% CO2–95% air,
culture media were collected and THP-1 macrophages were washed with PBS, scraped off
the plates and lysed twice for 50 s at 50 W by sonication. The Bradford protein assay [32]
was performed to measure the protein content of the lysates.
The levels of IL-6, IL-1β and TNF-α produced in the media were measured by ELISA
kits (Diaclone, Besançon, France; RayBiotech, Norcross, GA, USA; and Cloud-Clone, Katy,
TX, USA). In addition, ELISA kits were used to analyze the content of Akt, AMPK-α and
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NF-κB (ThermoFisher, Carlsbad, CA, USA for Akt and AMPK-α; and Cloud-Clone, Katy,
TX, USA for NF-κB) using the cell lysates. Absorbance was read at 450 nm.
2.11. Oil Red O Staining
THP-1 macrophages were incubated with TRLs at the same conditions as described
in Section 2.9. After incubation, macrophages were washed with PBS and treated with
1 mL of isopropanol 60% for 2 min. Once isopropanol was removed, 1 mL of Oil Red O
(0.2% (m/v) in 40% isopropanol/water (v/v)) was added and cells were incubated at room
temperature for 10 min. Oil Red O was removed, and cells were washed with PBS. Finally,
2 mL of glycerol 30% in water (v/v) was added for preservation for 3–4 days. An inverted
microscope Motic AE21 Series (Barcelona, Spain) coupled to a Moticam 2500 5.0M Pixel
Live Resolution camera (Motic, Barcelona, Spain) was used for microphotography.
2.12. Intracellular Fatty Acid Composition
For the analysis of fatty acids accumulated intracellularly, THP-1 macrophages were
incubated at the same conditions as described in Section 2.9. After incubation, cells were
washed with PBS, scraped off the plates and lysed twice for 50 s at 50 W by sonication. A
direct method of fatty acid methylation was carried out [33]. In brief, 10 µL of 15:0 fatty
acid at 1 mg/mL was added as an internal standard to 50 µL of cell lysates in a glass tube.
In total, 1.5 mL of methanolic HCl 3N was added and shaken for 30 s. Tubes were heated at
85 ◦C for 45 min, and after cooling down to room temperature, 0.5 mL of hexane was added
to each glass tube, shaken for 30 s and centrifuged at 1000 rpm for 5 min twice. Finally,
the upper phase of each tube was collected, evaporated under a stream of nitrogen and
concentrated to 75 µL of hexane. An aliquot of 1 µL was injected in a model 5890 series II
GC (Hewlett-Packard Co, Avondale, AZ, USA) equipped with a flame ionization detector
and a capillary silica column Supelcowax 10 (Supelco Co., Bellefonte, PA, USA) of 60 m
length and 0.25 mm internal diameter. Fatty acids were identified by comparison of their
retention times against those of standards and quantified by internal standard using peak
area integration.
2.13. Statistical Analysis
The data were expressed as mean ± standard error of mean (SEM), except olive oil
composition, which was expressed as mean ± standard deviation (SD). Values of Akt,
AMPK-α, NF-κB and intracellular fatty acids were normalized by the protein content of
the lysates. ANOVA followed by Tukey’s test was used for assessing the mean differences
among control and experimental groups in the cell experiments. Mean differences of the
baseline characteristics of adolescents were assessed by Student’s t-test. Statistical analyses
were carried out using IBM SPSS Statistics 24.0 (IBM Corp., Armonk, NY, USA) software.
GraphPad Prism 6 (San Diego, CA, USA) was used for figures.
3. Results
3.1. OA Effects on LPS-Stimulated THP-1 Macrophages
3.1.1. Effects of OA Pretreatment on THP-1 Cell Viability
The XTT assay was performed to determine cell viability when treated with OA. Cell
viability was not threatened by the presence of OA at all concentrations assayed with a
proportion of active cells that remained always above 87%. It was found that both DMSO
and LPS, at the applied concentrations, did not affect the viability of THP-1 cells (data are
shown in Figure S1).
3.1.2. IL-1β, IL-6 and TNF-α Release in LPS-Stimulated THP-1 Macrophages Pretreated
with OA
Our results show significant higher levels of IL-1β in LPS-stimulated macrophages pre-
treated with OA at 10 µM and 25 µM, in comparison to lower OA concentrations (Figure 1a).
IL-1β levels at the highest OA concentrations were similar to those of non-stimulated cells
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treated with DMSO only. Concerning IL-6 (Figure 1b) and TNF-α (Figure 1c), a signifi-
cant increase in the release of these cytokines in THP-1 macrophages treated with LPS
was observed in comparison to THP-1 macrophages only exposed to DMSO. However,
pretreatment with OA attenuated the release of IL-6 and TNF-α, especially at 25 µM.




Figure 1. Effects of OA on proinflammatory cytokines production by THP-1 macrophages induced 
by LPS. Control cells were incubated with DMSO. Experiments performed in triplicate. (a) IL-1β; 
(b) IL-6; (c) TNF-α. Different letters indicate significant difference (p < 0.05) by one-way ANOVA 
analysis and Tukey’s post hoc test. 
3.1.3. Levels of AMPK-α and Akt in LPS-Stimulated and OA-Pretreated  
THP-1 Macrophages 
AMPK-α levels in LPS-stimulated THP-1 cells increased dose-dependently up to 10 
μM. In contrast, at 25 μM, the concentration was lower than at 10 μM (Figure 2a). The 
LPS-stimulated THP-1 macrophages pretreated with 0.5 and 1 μM of OA had significantly 
lower levels of AMPK-α in comparison to non-LPS-stimulated THP-1 macrophages 
treated with DMSO. Therefore, 10 μM was the concentration at which OA was more 
Figure 1. Effects of OA on proinflammatory cytokines production by THP-1 macrophages induced
by LPS. Control cells were incubated with DMSO. Experiments performed in triplicate. (a) IL-1β;
(b) IL-6; (c) TNF-α. Different l tters indicate significant difference (p < 0.05) by one-way ANOVA
analysis and Tukey’s post hoc test.
3.1.3. Levels of AMPK-α and Akt in LPS-Stimulated and OA-Pretreated
THP-1 Macrophages
AMPK-α l vels in LPS-stimulated THP-1 cells increased dose-dependently up to
10 µM. In contrast, at 25 µM, the concentration was lower than at 10 µM (Figure 2a). The
LPS-stimulated THP-1 macrophages pretreated with 0.5 and 1 µM of OA had significantly
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lower levels of AMPK-α in comparison to non-LPS-stimulated THP-1 macrophages treated
with DMSO. Therefore, 10 µM was the concentration at which OA was more effective in
attenuating the dephosphorylation of AMPK-α induced by LPS. No significant differences
were observed in the levels of Akt (Figure 2b).
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Figure 2. Effects of OA on AMPK-α (a) and Akt (b) in THP-1 macrophages induced by LPS. Control cells were incubated
with DMSO. Experiments performed in triplicate. Different letters indicate significant differe ce (p < 0.05) by one-way
ANOVA analysis and Tukey’s post hoc test.
3.2. Postprandial Clinical Trial. Activation of THP-1 Macrophages with Human TRL
3.2.1. Anthropometric and Biochem cal Data of Adolescents at Baseline
Table S2 shows the anthropometric and bioch mical char cteristics of adolescents,
whose data were assessed prior to the postprandial trial. All data were within normal limits.
3.2.2. Effects of Human TRLs on the Production of Proinflammatory Cytokines in
THP-1 Macrophages
TRL-induced production of the proinflammatory cytokines IL-1β, IL-6 and TNF-α
on THP-1 macrophages is shown in Figure 3. At the same time point, cells stimulated
with 2 h postprandial TRL in adolescents that ingested the OA-enriched olive oil produced
lower levels of IL-6 than those treated with 2 h postprandial TRL after the intake of the
non-functional olive oil. Non-statistically significant differences were observed for IL-1β
and TNF-α.
We did not find statistically significant differences for any variable among the different
time points in the macrophages incubated with either olive oil derived TRLs or OA-enriched
olive oil TRLs.
3.2.3. Effects of Human TRLs on the Levels of Kinases and NF-κB in THP-1 Macrophages
The levels of AMPK-α and Akt proteins after incubation of THP-1 macrophages with
postprandial TRLs are shown in Figure 4. At the same time point, levels of Akt were higher
in macrophages stimulated with 2 h postprandial TRL of adolescents that ingested the
non-functional olive oil compared to PBS. In contrast, THP-1 macrophages stimulated with
2 h postprandial TRL after the intake of the functional olive oil presented levels of Akt
similar to PBS. No significant differences in levels of AMKP-α and NF-κB were observed.
No significant differences for kinases and NF-κB were observed at the different time
points in either the macrophages incubated with olive oil-derived TRLs or with OA-
enriched olive oil-derived TRLs.
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Figure 3. TRL production of proinflammatory cytokines by THP-1 macrophages incubated with
TRLs obtained from healthy adolescents before, and at 2 and 5 h after the intake an OA-enriched
olive oil or non-functional olive oil. Control cells incubated with PBS. (a) IL-1β; (b) IL-6; (c) TNF-α.
* p < 0.05.
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3.2.4. Intracellular Lipid Accumulation
Figure 5 shows microphotographs of intracellular lipids stained with Oil Red O. The
lipid content was higher in TRL-treated cells, independent of the presence of OA. The fatty
acid content of total lipids accumulated intracellularly by THP-1 macrophages after being
incubated for 48 h in the absence (control) or presence of TRLs isolated at baseline, 2 and
5 h after the consumption of the OA-enriched or non-functional olive oils are shown in
Table 1. A higher oleic acid (18:1) content was found in cells incubated with TRLs obtained
2 h after the intake of the experimental meals compared to control but not compared to
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the other time points studied. For the rest of the fatty acids, no differences were found
compared to either the control or other time points.
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Table 1. Intracellular fatty acid composition of total lipids in THP-1 macrophages after incubation with TRLs derived from
two different olive oils.
0 Hour 2 Hours 5 Hours
Fatty Acids Control Olive Oil OA-EnrichedOlive Oil Olive Oil
OA-Enriched
Olive Oil Olive Oil
OA-Enriched
Olive Oil
12:0 41.46 ± 3.41 41.68 ± 4.26 38.93 ± 3.23 42.10 ± 5.51 41.02 ± 2.21 35.63 ± 4.93 40.06 ± 6.80
14:0 45.00 ± 3.33 48.13 ± 4.26 42.41 ± 2.38 48.18 ± 4.30 40.71 ± 3.10 40.94 ± 2.95 41.41 ± 4.56
16:0 95.68 ± 16.74 158.11 ± 26.64 151.96 ± 26.97 171.74 ± 19.10 148.57 ± 24.76 130.98 ± 20.06 180.53 ± 48.50
18:1 60.16 ± 6.51 119.58 ± 24.85 104.55 ± 22.00 126.60 ± 13.02 * 119.88 ± 19.83 102.02 ± 14.42 145.63 ± 44.69
18:2 46.68 ± 6.07 45.22 ± 4.12 40.83 ± 3.43 56.26 ± 11.56 41.65 ± 3.45 37.49 ± 2.99 40.59 ± 4.35
20:4 41.74 ± 1.30 51.22 ± 16.64 63.37 ± 17.74 46.04 ± 4.73 43.44 ± 6.23 42.60 ± 11.64 35.02 ± 1.65
Others 79.37 ± 9.00 ND 59.97 ± 26.24 ND ND ND 155.12 ± 0.57
Data are presented as mean ± SEM. Controls performed in triplicate. Experimental groups (n = 11). * p < 0.05 vs. control. Statistical
differences were analyzed among control, olive oil and the OA-enriched olive oil at the same time point and at different time points. ND,
not detected.
4. Discussion
In the present work, we evaluated the ability of OA to attenuate the overproduction
of proinflammatory cytokines and to modulate signaling pathways in THP-1 macrophages
stimulated by LPS, as well as its activity when forming part of human TRLs obtained after
the intake of an olive oil enriched in the triterpene. The main findings presented here are
(i) pretreatment with OA attenuated the LPS-induced overproduction of pro-inflammatory
cytokines, especially of IL-6, but also TNF-α, in THP-1 macrophages; (ii) levels of AMPK-α
were increased by OA in a dose-dependent manner in LPS-stimulated THP-1 macrophages;
and (iii) OA-enriched olive oil alleviated the levels of IL-6 and Akt in THP-1 macrophages
stimulated with 2 h postprandial TRLs.
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LPS is widely used in experiments to induce an inflammatory response, and numerous
studies have shown an overproduction of IL-1β, IL-6 and TNF-6 in THP-1 cells stimulated
by LPS [34–36]. In our study, the activation of THP-1 macrophages with LPS produced
an abundant release of IL-6, IL-1β and TNF-α in the cell culture supernatants. However,
pretreatment with OA attenuated IL-6 levels, especially at 25 µM. At that concentration,
OA was also able to reduce TNF-α release by the cells. Similar results were reported by
Castellano et al. [37] in LPS-activated BV-2 microglia, where the overproduction of IL-6
was attenuated in a dose-dependent manner by OA. In contrast, unexpected results were
reported in our study for LPS-induced production of IL-1β, since a dose-dependent increase
of this cytokine by OA was observed. Interestingly, LPS-stimulated THP-1 macrophages
pretreated with the highest concentrations of OA released similar values of IL-1β than the
control. It has been reported that DMSO induces IL-1β secretion in THP-1 macrophages by
activating the enzyme caspase-1 [38,39]. This could partly explain our findings, since OA
was dissolved in DMSO, and the cells that received the higher doses of OA also received
higher DMSO volumes. Nevertheless, DMSO is a common solvent for water-insoluble
substances, such as OA, in this kind of experiment [39,40].
The effects of OA on proinflammatory cytokines produced by THP-1 macrophages,
especially IL-6, might be explained by the modulatory role of AMPK on inflammation
processes. In order to become active, AMPK needs to be phosphorylated at its α-subunit
(Thr172 residue) [41,42]. It has been reported that LPS induces the dephosphorylation of
AMPK [42]. Therefore, to achieve a better understanding of the anti-inflammatory ability of
OA in THP-1 macrophages, the levels of phosphorylated AMPK-α were measured. A sig-
nificant reduction of LPS-induced dephosphorylation of AMPK-α was observed at 10 µM of
OA. In line with our study, Liu et al. [43] reported that δ-oleanolic acid could stimulate the
phosphorylation of AMPK in THP-1 macrophages. In the same way, Matumba et al. [44]
reported an increase in the AMPK gene expression and a reduction of IL-6 and TNF-α gene
expression in high-fructose diet-fed rats treated with OA. Furthermore, the application
of an OA derivative, 3-acetyl-oleanolic acid, to rats fed with a high-fructose diet has been
shown to significantly increase the phosphorylation of AMPK in the liver tissues [45].
Therefore, OA seems to have a key role in the alleviation of inflammatory status through
regulating AMPK phosphorylation.
Indeed, AMPK is believed to be one of the main mechanisms of the biological activ-
ity of OA, as well as other triterpenic compounds. OA modulates glucose uptake, fatty
acid oxidation in the muscle and fatty acid synthesis and gluconeogenesis in the liver by
stimulating AMPK phosphorylation [46]. Another reported signaling pathway underlying
the metabolic effects of OA is PI3K/Akt. For instance, OA and its derivatives have been
shown to stimulate Akt in vascular smooth muscle cells [47], and to relieve inflammation in
different experimental models [48–50]. However, not all OA derivatives have the same in-
flammatory effect through Akt. Jin et al. [51] prepared eleven oxooleanolic acid derivatives
using OA as starting compounds for structural modification, and found that only two of
them exerted significant anti-inflammatory effects on BV-2 cells by the activation of NF-κB,
MAPKs and PI3K/Akt. In addition, in bone marrow macrophages, OA showed no sig-
nificant inhibitory effects on receptor activator of nuclear factor kappa-B ligand-activated
expression of NF-κB, p38, JNK and Akt [52]. However, in our study, OA was unable to
significantly reduce Akt levels. There are three homologous Akt isoforms that are activated
by similar mechanisms, Akt1, Akt2 and Akt3 [53]. In THP-1 macrophages, Shiratsuchi and
Basson [54] found that Akt2 but not Akt1 and Akt3 mediated phagocytosis stimulated by
pressure. Since we measured total Akt, the absence of a clear effect might be related to
opposing roles of the different isoforms. In the same way, a Mg-based alloy inhibited the
inflammatory response of THP-1 cell-derived macrophages through the inhibition of Akt1
but not total Akt [55]. Therefore, further studies are needed to clarify the participation
of Akt isoforms in the regulation of proinflammatory cytokines in THP-1 macrophages
by OA.
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Postprandial TRL participates in the atherosclerotic process through promoting foam
cell formation from macrophages, in which the secretion of pro-inflammatory substances
plays an important role [56,57]. The induction of THP-1 macrophages in our study with 2 h
postprandial TRLs derived from the OA-enriched olive oil showed significant lower levels
of IL-6 but not IL-1β and TNF-α, compared to the TRLs derived from olive oil. Our results
have some similarities with the study performed by Graham et al. [58] with postprandial
TRLs from healthy adults. They reported lower levels of IL-6 in THP-1 cells incubated with
4 h TRLs derived from pomace olive oil, which was attributed to the presence of OA in
the oil. In addition, and in agreement with our results, chylomicron remnants, a form of
TRL, but not native chylomicrons or oxLDL, did not increase IL-1β and TNF-α in vascular
smooth muscle cells, which are also involved in atherogenesis, despite increased monocyte
chemoattractant protein (MCP)-1 mRNA expression [59,60].
The potential role of OA might be due to its repressive action on NF-κB, which has
been shown to be activated by TRLs [61]. Although we did not find significant influences
of TRL on NF-κB, levels of this factor were slightly lower in macrophages treated with
postprandial TRL derived from OA-enriched olive oil. The effect of TRLs on NF-κB
is highly dependent upon their fatty acid composition. De Pascale et al. [62] used lab-
made TRLs to induce foam cell formation in PMA-activated THP-1 macrophages, and
found a lowering effect on the NF-κB binding of polyunsaturated fatty acids, but not
by monounsaturated fatty acids. Since the TRLs employed in the present study were
obtained after the intake of olive oil, which is rich in monounsaturated fatty acids, the
lack of a statistically significant effect of these particles on NF-κB might be related to their
fatty acid composition, with no intervention of OA. In contrast, at 2 h, TRLs obtained
from the control olive oil significantly increased Akt levels, which were ameliorated when
these lipoproteins were isolated after the intake of the OA-enriched oil. The application
of postprandial very low-density lipoproteins (VLDL) to peripheral blood mononuclear
cells and THP-1 monocytes by den Hartigh et al. [63] produced an overexpression of Akt
phosphorylation, which, in contrast to our study, was accompanied by increased gene
expression levels of TNF-α and IL-1β. Unfortunately, these authors did not measure IL-6
in the culture medium.
The intracellular lipid accumulation after administering postprandial TRLs into THP-1
macrophages varies depending on several factors, including the postprandial time at which
TRLs are isolated [56]. Cabello-Moruno et al. [56], Graham et al. [58], Perona et al. [64] and
Cabello-Moruno et al. [65] have repeatedly showed that the intracellular lipid composition
is very dependent on the composition of TRLs, which in turn, reflects that of the ingested
oils. Nevertheless, we previously demonstrated that minor components of pomace olive oil
can also modify postprandial TRL composition and the clearance of TG molecular species
of postprandial TRL [66]. Therefore, it was reasonable to suggest that the presence of OA
in TRL would affect the intracellular lipid composition of THP-1 macrophages. However,
we only found slight changes in the oleic acid content of intracellular lipids. This is, in
fact, in agreement with previous reports. In the study by Graham et al. [58], no differences
were found in the intracellular lipid content when THP-1 macrophages were incubated
with TRLs obtained 2 h or 4 h after the intake of virgin, pomace and OA-enriched pomace
olive oil.
The present study shows that OA is capable of alleviating the proinflammatory cy-
tokines overproduction in THP-1 macrophages, probably due to the enhancement of
AMPK-α levels. The effect was also observed when cells were treated with OA as part of
postprandial TRLs, as obtained from the blood of adolescents after the intake of a functional
olive oil enriched with the triterpene. Therefore, OA has potential anti-atherogenic activity
and might be considered to be used in functional foods, at least in adolescents.
This work has some strengths and limitations. For the first time a formulation of olive
oil enriched with the triterpene OA has been used in a postprandial trial performed on
a population of adolescents. TRLs isolated from adolescent blood and different concen-
trations of OA were supplied to THP-1 macrophages, obtaining interesting results that
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must be interpreted with caution, due to its difficult generalization to other cells or whole
organisms. Nevertheless, our results offer new data on OA effects on signaling pathways,
allowing a better understanding of the mechanisms of OA action.
5. Conclusions
In summary, pretreatment of THP-1 macrophages with OA attenuated the overpro-
duction of proinflammatory cytokines, especially of IL-6, and enhanced the AMPK-α levels
in a dose-dependent manner. Therefore, we conclude that OA has potential to treat insulin
resistance due to its capability to alleviate the inflammatory response through modulat-
ing the activity of AMPK-α. In regard to the results reported on the postprandial trial,
TRLs obtained from adolescents 2 h after the ingestion of the functional olive oil led to
lower levels of IL-6 and Akt in macrophages. These results suggest that OA could have
the potential to be used as a lipid-based formulation in functional olive oils to prevent
and treat insulin resistance, atherogenic impairments and the different metabolic factors
underlying MetS in adolescents. However, further cell experiments using OA and clinical
trials with OA-enriched olive oil must be performed in order to obtain more solid data
to allow the future use of OA as a nutraceutical in the preventive strategies of MetS and
insulin resistance.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
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Table S2: Baseline anthropometric and biochemical characteristics of adolescents according to the
olive oil ingested at breakfast.
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